Henry Schein stock holds near $90 after Reuters-linked IPO jitters
Published on 08/31/2026 at 22:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Henry Schein (US42548G1040) traded at $89.52 on August 28, 2026, with a $9.977 billion market cap and a 52-week range of $61.95 to $92.18. The stock was down 0.84% in the latest quote snapshot, while its YTD return stood at 18.44%.
Latest trading setup
The move leaves Henry Schein close to its 52-week high of $92.18 and above the S&P 500's 12.65% YTD gain shown in the same quote view. Volume was 795,954 versus an average of 1,288,788 shares, which puts the session below normal turnover.
That backdrop matters because the same market snapshot shows a $98.19 average analyst target and a $110 target from BTIG dated August 19, 2026. The gap between the last close and the newer target gives the stock a clear valuation debate even without a fresh company filing.
What the last quarter showed
Henry Schein's Q2 FY26 results came in with $3.46 billion in revenue, $94 million in earnings, and a 2.72% profit margin. EPS was $1.27 versus an estimate of $1.24, a $0.03 beat that kept the focus on execution rather than just valuation.
The same quote page also flags trailing revenue of $13.6 billion, net income of $403 million, and diluted EPS of $3.43. Free cash flow was $446 million on a levered basis, while total debt-to-equity sat at 80.73%.
Product mix
Henry Schein sells health care products and services to office-based dental and medical practices, with distribution, specialty products, and technology as its main segments. Its catalog spans infection-control supplies, dental equipment, pharmaceuticals, practice-management software, and repair services.
Stock level
At $89.52 as of August 28, 2026, Henry Schein shares are trading just below the recent high set in the same quote snapshot. The stock has gained 29.68% over the past year, which keeps the current debate centered on whether that run can extend beyond the next earnings date of November 3, 2026.
Fact box
Company: Henry Schein, Inc.
ISIN: US42548G1040
Ticker: HSIC
Exchange: Nasdaq
Sector / Industry: Healthcare / Medical Distribution
Index membership: Nasdaq-100
Price (as of August 28, 2026, 4:00 p.m. ET): $89.52 USD
Market cap: $9.977 billion (as of August 28, 2026)
Next earnings date: November 3, 2026
